DIABNEX lauréat du Trailblazer Award 2017


DIABNEXT – Our next-generation Diabetes care platform using A.I. and auto-filled health metrics won on Sept. 16th 2018 the Medical Device Company of the Year Trailblazer Gold winner.

PM360 is the premier, magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. The PM360 Trailblazer Awards Gala draws more pharma participation than any other industry event.

Laurent NICOLAS, Founder & CEO, declared: “We want patients to live their lives, not their disease. We have developed DIABNEXT with a patient-first vision, to help diabetes patients manage their data every day. We are so honored to win this prestigious “Medical Device Company of the Year” award. Our dedication to diabetic patients is what drives our company’s success around the world, and this recognition further validates that our solutions are bringing great value to managing this grueling Chronic Disease. With many awards in our industry under our belt, DIABNEXT will be here in New York again to win the final round of Best French Founder US Start-up, next week on September 18th!”

Since 2009, the PM360 Trailblazer awards have recognized outstanding achievement and innovation in healthcare marketing. Each year, nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts. Gold winners are selected in each of the five Company of the Year categories: Pharma/Biotech Company, Medical Device/Diagnostics Company, Specialty Pharma/Biotech Company, Advertising Agency, and Supplier/Vendor. Winning companies are selected based on their ability to excel in three main aspects: Innovation, talent development and social responsibility.